<SEC-DOCUMENT>0001104659-25-119967-index.html : 20251210
<SEC-HEADER>0001104659-25-119967.hdr.sgml : 20251210
<ACCEPTANCE-DATETIME>20251210160119
ACCESSION NUMBER:		0001104659-25-119967
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20251210
DATE AS OF CHANGE:		20251210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Addex Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001574232
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291644
		FILM NUMBER:		251561913

	BUSINESS ADDRESS:	
		STREET 1:		CHEMIN DES MINES 9
		CITY:			GENEVA
		STATE:			V8
		ZIP:			CH-1202
		BUSINESS PHONE:		01141228841555

	MAIL ADDRESS:	
		STREET 1:		CHEMIN DES MINES 9
		CITY:			GENEVA
		STATE:			V8
		ZIP:			CH-1202
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>tm2531595-4_424b5.htm
<DESCRIPTION>424B5
<TEXT>
Document 1 - file: tm2531595-4_424b5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_addextherapeutics-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_addextherapeutics-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tb_partneredprog-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: tb_partneredprog-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tb_drugcandi-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tb_drugcandi-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tb_researchprog-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tb_researchprog-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tb_neurosterix-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: tb_neurosterix-4clr.jpg

</DOCUMENT>
</SEC-DOCUMENT>